Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults

ClinicalTrials.gov ID: NCT00746798

Public ClinicalTrials.gov record NCT00746798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Modified, Double-blind, Placebo-controlled, Phase II, Dose-ranging Study of the Safety and Immunogenicity of Single Dose ChimeriVax-WN02 Vaccine in Healthy Adults.

Study identification

NCT ID
NCT00746798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
479 participants

Conditions and interventions

Interventions

  • ChimeriVax-WN02 vaccine Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
May 31, 2009
Completion
Nov 30, 2009
Last update posted
Apr 2, 2015

2008 – 2009

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Advanced Clinical Research Inst. Anaheim California 92801
Lynn Health Science Institute Colorado Springs Colorado 80909
Miami Research South Miami Florida 33143
Advanced Clinical Research- Idaho Boise Idaho 83642
Idaho Falls Infectious diseases Idaho Falls Idaho 83404
Johnson County Clinical Trials Lenexa Kansas 66219
Vince & Associates Overland Park Kansas 66211
Bio-Kinetic Springfield Missouri 65802
Big Sky Clinical Research Butte Montana 59701
Infectious Disease Specialists, PC Missoula Montana 59802
Odyssey Research Fargo North Dakota 88104
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Research Across America Dallas Texas 75234
Benchmark Fort Worth Texas 76135
Radiant Research Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00746798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00746798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →